Skip to main content
. 2021 Jul 5;2021(7):CD011301. doi: 10.1002/14651858.CD011301.pub2

28.1. Analysis.

28.1

Comparison 28: OnabotulinumtoxinA 20units versus placebo in glabellar lines three cycles of treatment, Outcome 1: Any major adverse events (eyelid ptosis, eyelid sensory disorder, strabismus)